Stuart Therapeutics is developing innovative therapies for chronic ophthalmic disease. Our focus is on a promising patented technology platform, PolyCol. PolyCol is a collagen mimetic peptide that rapidly heals damaged tissue, and has demonstrated extremely positive performance in animal studies. PolyCol for dry eye is unique in comparison to competing therapies, and is the only direct healing therapeutic for damage to the ocular surface.